Michael P. King
Keine laufenden Positionen mehr
Profil
Michael P.
King worked as Head of US Strategic Planning at Sandoz, Inc., Chief Financial & Business Officer at Aprecia Pharmaceuticals Co., and Consultant at McKinsey & Co., Inc. He also worked as Principal at the Association for Accessible Medicines.
His most recent former job was as Chief Financial Officer at PDS Biotechnology Corp.
Mr. King received his undergraduate degree from Wesleyan University and his MBA from Columbia Business School.
Ehemalige bekannte Positionen von Michael P. King
Unternehmen | Position | Ende |
---|---|---|
PDS BIOTECHNOLOGY CORPORATION | Finanzdirektor/CFO | 01.01.2021 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Corporate Officer/Principal | - |
Aprecia Pharmaceuticals Co.
Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Aprecia Pharmaceuticals Co. manufactures and develops drugs. It offers ZipDose and three dimension printing technology platforms. The firm utilizes the 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. The company was founded in 2003 and is headquartered in Langhorne, PA. | Finanzdirektor/CFO | - |
Ausbildung von Michael P. King
Wesleyan University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PDS BIOTECHNOLOGY CORPORATION | Health Technology |
Private Unternehmen | 4 |
---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Aprecia Pharmaceuticals Co.
Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Aprecia Pharmaceuticals Co. manufactures and develops drugs. It offers ZipDose and three dimension printing technology platforms. The firm utilizes the 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. The company was founded in 2003 and is headquartered in Langhorne, PA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |